KENTA BIOTECH
Kenta Biotech is focusing on the discovery and development of innovative, fully human monoclonal antibodies for the life-saving treatment of patients with serious infectious diseases. For the discovery of their monoclonal antibodies, they are using their proprietary MabIgX technology platform that enables the generation of an advanced class of fully human monoclonal antibodies that are expected to have superior safety and efficacy profiles.
KENTA BIOTECH
Social Links:
Industry:
Biotechnology Medical
Founded:
2006-01-01
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.kentabiotech.com
Total Employee:
11+
Status:
Active
Contact:
41 58 680 52 52
Email Addresses:
[email protected]
Total Funding:
12 M CHF
Technology used in webpage:
Nginx Baidu Analytics QuickPacket
Similar Organizations
PanGenetics
PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
